A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes

Rheum Dis Clin North Am. 2017 Aug;43(3):489-502. doi: 10.1016/j.rdc.2017.04.013.

Abstract

The evidence to date regarding corticosteroid exposure in pregnancy and select pregnancy and birth outcomes is limited and inconsistent. The authors provide a narrative review of published literature summarizing the findings for oral clefts, preterm birth, birth weight, preeclampsia, and gestational diabetes mellitus. Whenever possible, the results are limited to oral or systemic administration with a further focus on use in autoimmune disease. Although previous studies of corticosteroid exposure in pregnancy reported an increased risk of oral clefts in the offspring, more recent studies have not replicated these findings.

Keywords: Adverse pregnancy and birth outcomes; Corticosteroids; Pregnancy; Review.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Autoimmune Diseases / drug therapy*
  • Female
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / pharmacology
  • Humans
  • Mouth Abnormalities / chemically induced*
  • Placenta / drug effects
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Outcome
  • Risk Factors

Substances

  • Glucocorticoids